Ticker > Company >

Deccan Health Care share price

Deccan Health Care Ltd.

BSE: 542248 SECTOR: Pharmaceuticals & Drugs  20.06 K   48   5

19.25
0 0
BSE: 12 Sep 04:01 PM

Price Summary

Today's High

₹ 20.24

Today's Low

₹ 18.8

52 Week High

₹ 32.89

52 Week Low

₹ 16

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

45.09 Cr.

Enterprise Value

44.28 Cr.

No. of Shares

2.34 Cr.

P/E

43.36

P/B

0.42

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  45.58

CASH

2.22 Cr.

DEBT

1.41 Cr.

Promoter Holding

18.42 %

EPS (TTM)

₹  0.44

Sales Growth

32.67%

ROE

1.72 %

ROCE

2.54%

Profit Growth

282.82 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Deccan Health Care Ltd.

Lignofiax OxyFlax NANO Lotorin OmegaMax TOTAL Omega Max M Neurovit MC Neurovit MC Total ReactiveGo Ostohealth Stay Young Slim Meal Orthomega Stay Young Protein Shake O3D3 Lignofiax Stay Young Food Pill OxyFlax Global Lotorin Lignofiax CardoDecc Maxicare O7 I-Brite XtraJOSH ProstaDecc

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year32.67%
3 Year20.93%
5 Year6.18%

Profit Growth

1 Year282.82%
3 Year57.44%
5 Year-36.28%

ROE%

1 Year1.72%
3 Year0.88%
5 Year3.46%

ROCE %

1 Year2.54%
3 Year1.41%
5 Year3.85%

Debt/Equity

0.0147

Price to Cash Flow

-3.61

Interest Cover Ratio

35.6662

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 18.42 0.00
Mar 2025 19.46 0.00
Dec 2024 18.26 0.00
Sep 2024 15.66 0.00
Jun 2024 16.12 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 20.9276088547057% for the Past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 35.6662.
  • Company’s PEG ratio is 0.196857229250513.
  • Company has a healthy liquidity position with current ratio of 12.2475.

 Limitations

  • Company has a poor ROE of 0.879830956515926% over the past 3 years.
  • Company has a poor ROCE of 1.41140099137297% over the past 3 years
  • Company has negative cash flow from operations of -12.4808.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 15.06 18.82 20.43 20.82 21.47
Total Expenditure 14.19 17.71 19.84 20.2 20.75
Operating Profit 0.87 1.11 0.59 0.62 0.72
Other Income 0 0 0 0.01 0.01
Interest 0.02 0.03 0.02 0.02 0.02
Depreciation 0.36 0.37 0.37 0.36 0.41
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.49 0.72 0.21 0.25 0.3
Tax 0.12 0.18 0.06 0.11 0.09
Profit After Tax 0.37 0.54 0.16 0.14 0.21
Adjusted EPS (Rs) 0.18 0.26 0.07 0.06 0.09

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 42.24 33.78 33.17 45.02 59.73
Total Expenditure 30.57 31.74 27.82 42.97 55.98
Operating Profit 11.68 2.04 5.35 2.05 3.75
Other Income 0.06 0.06 0.22 0.02 0.02
Interest 0.18 0.11 0.15 0.12 0.06
Depreciation 1.42 1.47 1.47 1.43 1.47
Exceptional Items 0 0 -3.4 0 0
Profit Before Tax 10.13 0.52 0.54 0.53 2.24
Tax 0.04 0.13 0.22 0.13 0.72
Net Profit 10.09 0.39 0.32 0.4 1.52
Adjusted EPS (Rs.) 6.42 0.25 0.21 0.23 0.75

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 15.71 15.71 15.71 17.04 20.38
Total Reserves 60.52 60.91 61.23 64.61 76.66
Borrowings 0.87 0.67 0.96 0.6 1.19
Other N/C liabilities 2.29 2.27 2.24 2.08 1.96
Current liabilities 13.6 12.71 10.49 12.14 7.14
Total Liabilities 92.99 92.27 90.63 96.47 107.33
Assets
Net Block 21.25 19.87 18.53 16.85 15.69
Capital WIP 0 0 0 0 0
Intangible WIP 0 0.07 0 0 0
Investments 0 0.01 0.01 0.01 0.01
Loans & Advances 3.64 3.5 1.77 1.77 1.78
Other N/C Assets 2.25 2.37 2.37 2.39 2.39
Current Assets 65.86 66.45 67.95 75.45 87.45
Total Assets 92.99 92.27 90.63 96.47 107.33
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 10.13 0.52 3.94 0.53 2.24
Adjustment 1.59 1.57 -1.78 0.86 1.52
Changes in Assets & Liabilities -9.03 -1.73 -2.49 -7.77 -15.39
Tax Paid 0 -0.14 -0.25 -0.22 -0.86
Operating Cash Flow 2.68 0.22 -0.57 -6.59 -12.48
Investing Cash Flow -1.94 -0.08 -0.05 0.26 -0.3
Financing Cash Flow -1.77 -0.37 0.07 5.06 13.64
Net Cash Flow -1.03 -0.23 -0.55 -1.27 0.86

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 16.12 15.66 18.26 19.46 18.42
meenakshi gupta - - - 5.00 4.74
minto purshotam gupta 10.34 10.04 13.06 14.46 13.68
bhavna hitesh patel 0.02 0.02 0.02 - -
hitesh mohan patel 0.01 0.01 0.01 - -
meenakshi gupta 5.75 5.58 5.17 - -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 83.88 84.34 81.74 80.54 81.58
focal ventures private li... 18.81 13.72 10.02 9.69 14.06
hiral saurabh shah - 1.43 1.76 1.71 1.62
kaushal ashwin gandhi 1.33 1.29 - 2.27 2.15
kolla sangeetha - - 2.68 2.60 2.46
kolla umanja venkata saty... - 7.43 6.87 6.65 6.30
krishna ventures - - 3.67 5.05 5.25
nihir chandrakant shah 2.70 2.62 2.42 2.35 2.22
prasad rajnikant sheth 1.74 1.69 1.57 1.52 1.44
punit vikram sheth - - - 1.10 1.04
surinder kaur - - - 1.28 1.21
venture gurukool investme... 6.53 6.34 5.87 5.68 5.37
vikram sharad sheth 4.21 3.57 3.32 2.31 2.41
ritika bhandari 2.83 2.25 1.91 - -
k a gandhi (huf) 1.33 1.29 - - -
kinjal kaushal gandhi 1.33 1.29 - - -
sudhir singal 1.04 1.01 - - -
hiral jagdish malekar 1.47 - - - -
mehul kishore joshi 1.22 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2021
Annual Report 2020
Annual Report 2019

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q1FY25

Company News

Deccan Health Care informs about updates 4 Sep, 4:46 PM Deccan Health Care - Quaterly Results 14 Aug, 4:10 PM Deccan Health Care - Quaterly Results 14 Aug, 4:10 PM Deccan Health Care - Quaterly Results 14 Aug, 4:10 PM Deccan Health Care submits certificate 14 Jul, 5:01 PM Deccan Health Care informs about EGM 16 Jun, 5:19 PM Deccan Health Care - Quaterly Results 29 May, 4:15 PM Deccan Health Care - Quaterly Results 14 Feb, 4:30 PM Deccan Health Care informs about resignation of CS 21 Dec, 4:44 PM Deccan Health Care informs about updates 21 Dec, 4:35 PM Deccan Health Care - Quaterly Results 31 Jul, 4:16 PM Deccan Health Care - Quaterly Results 31 Jul, 4:16 PM Deccan Health Care - Quaterly Results 31 Jul, 4:16 PM Deccan Health Care - Quaterly Results 6 Feb, 4:21 PM Deccan Health Care - Quaterly Results 6 Feb, 4:21 PM Deccan Health Care - Quaterly Results 6 Feb, 4:21 PM Deccan Health Care informs about newspaper publication 5 Sep, 4:52 PM Deccan Health Care informs about PCS certificate 20 Apr, 2:55 PM Deccan Health Care informs about trading window closure 1 Apr, 4:00 PM Deccan Health Care informs about appointment of CFO 13 Mar, 4:11 PM Deccan Health Care informs about appointment of director 13 Mar, 2:30 PM Deccan Health Care informs about board meeting 10 Mar, 12:09 PM Deccan Health Care informs about resignation of CS 8 Dec, 2:35 PM Deccan Health Care raises Rs 4.99 crore from Venture Gurukool Investment Trust 13 Jun, 2:58 PM Deccan Health Care informs about revised notice of postal ballot 5 May, 2:47 PM Deccan Health Care informs about postal ballot notice 26 Oct, 12:07 PM Deccan Health Care informs about disclosure 14 Oct, 9:49 AM Deccan Health Care informs about board meeting 13 Oct, 11:16 AM Deccan Health Care informs about outcome of board meeting 7 Sep, 9:57 AM Deccan Health Care ropes in advisor to augment online growth strategies 20 Apr, 3:14 PM Deccan Health Care informs about appointment of an advisor 20 Apr, 11:40 AM Deccan Health Care informs about compliance certificate 17 Apr, 3:47 PM Deccan Health Care informs about outcome of board meeting 1 Mar, 2:58 PM Deccan Health Care informs about board meeting 28 Dec, 4:42 PM Deccan Health Care informs about certificate 8 Oct, 3:06 PM Deccan Health Care introduces ‘Immunity Booster’ 6 Oct, 2:28 PM Deccan Health Care receives HealthCare Excellence award 2020 13 Jul, 10:48 AM Deccan Health Care incorporates WoS Company 26 Jun, 10:47 AM

Deccan Health Care Stock Price Analysis and Quick Research Report. Is Deccan Health Care an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Deccan Health Care. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Deccan Health Care has a PE ratio of 43.3558558558559 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Deccan Health Care has ROA of 1.4933% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Deccan Health Care has a Current ratio of 12.2475.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Deccan Health Care has a ROE of 1.7161%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Deccan Health Care has a Debt to Equity ratio of 0.0147 which means that the company has low proportion of debt in its capital.

  • Sales growth: Deccan Health Care has reported revenue growth of 32.6672% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Deccan Health Care for the current financial year is 6.27803291204092%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Deccan Health Care is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Deccan Health Care is Rs 0.444. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Deccan Health Care in Ticker for free. Also, one can get the intrinsic value of Deccan Health Care by using Valuation Calculators, which are available with a Finology ONE subscription. 

Deccan Health Care FAQs

Q1. What is Deccan Health Care share price today?
Ans: The current share price of Deccan Health Care is Rs 19.25.

Q2. What is the market capitalisation of Deccan Health Care?
Ans: Deccan Health Care has a market capitalisation of Rs 45.094112525 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Deccan Health Care?
Ans: The PE ratio of Deccan Health Care is 43.3558558558559 and the P/B ratio of Deccan Health Care is 0.422369570082631, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Deccan Health Care share?
Ans: The 52-week high share price of Deccan Health Care is Rs 32.89, and the 52-week low share price of Deccan Health Care is Rs 16.

Q5. Does Deccan Health Care pay dividends?
Ans: Currently, Deccan Health Care does not pay dividends. Dividend yield of Deccan Health Care is around 0%.

Q6. What are the face value and book value of Deccan Health Care shares?
Ans: The face value of Deccan Health Care shares is Rs 10, while the book value per share of Deccan Health Care is around Rs 45.5762. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Deccan Health Care?
Ans: Deccan Health Care has a total debt of Rs 1.4064 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Deccan Health Care?
Ans: The ROE of Deccan Health Care is 1.7161% and ROCE of Deccan Health Care is 2.5407%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Deccan Health Care a good buy for the long term?
Ans: The Deccan Health Care long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Deccan Health Care undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Deccan Health Care appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Deccan Health Care’s financials?
Ans: You can review Deccan Health Care’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Deccan Health Care
X